Verastem Reports Q3 2026 Financial Results with Earnings and Revenue Miss
Verastem reported third-quarter financial results that fell short of market expectations. The company posted a Non-GAAP earnings per share (EPS) of -$0.72, missing estimates by $0.28. While revenue grew significantly by 114.4% year-over-year to reach $24.01 million, this figure also missed consensus estimates by $2.07 million. Despite the earnings miss, Verastem maintains a strong liquidity position. The company ended the quarter with $172.8 million in cash, cash equivalents, and investments. Including gross proceeds from its October public offering, the pro-forma cash position is expected to reach approximately $422.8 million.
Topics: cash position earnings miss public offering revenue growth